Introduction
UPS, is indicative of impaired UPS function in PD. Exposure to pharmacological inhibitors of the proteasome replicates some biochemical and pathological characteristics of PD cell culture and animal models. Proteasome inhibition has been previously
shown to result in ␣-synuclein protein aggregation and cell death in various cell models including mesencephalic dopaminergic neurons [2] . The Parkinsonian toxin MPTP has been shown to cause UPS dysfunction and protein aggregation in the substantia nigra [5, 6] . Additionally, other neurotoxic pesticides linked to PD such as rotenone and dieldrin cause proteasome inhibition and protein aggregation [2] . Systemically administered proteasome inhibitors produce inconsistent results in producing Parkinsonian-like pathology in rodents [7] [8] [9] [10] [11] [12] .
Recently, we and others demonstrated that microinjection of proteasome inhibitors into substantia nigra or striatum effectively reproduces a nigrostriatal dopamine degeneration [13] [14] [15] .
Despite extensive observations of defective UPS degradation in PD pathogenesis, the cellular and molecular mechanisms leading to dopamine neuronal death following proteasomal dysfunction remain to be characterized. In the present study, we report for the first time that proteolytic activation and mitochondrial translocation of PKC␦ play a critical role in apoptotic cell death during proteasome dysfunction in dopaminergic neuronal cells.

Materials and methods
Cell culture and treatment paradigm
The immortalized rat mesencephalic dopaminergic cell line (N27 cells) was grown in RPMI 1640 medium containing 10% fetal bovine serum, 2 mM L-glutamine, 50 units penicillin and 50 g/ml streptomycin in a humidified atmosphere of 5% CO2 at 37ЊC [16, 17] 
Mitochondria depolarization assay
ROS assay
Flow cytometric analysis of reactive oxygen species in N27 cells was performed with dihydroethidine, as described previously [18] [19] [20] [21] 
PKC␦ kinase assay
The enzymatic activity of PKC␦ was measured with an immunoprecipitation kinase assay, as described previously [23] . Cells were lysed with lysis buffer (25- 
Immunocytochemistry and TUNEL staining
Immunofluorescence staining was conducted as described previously [25] . Briefly, 24 in Fig. 1D (Fig. 2D) . Notably, caspase-3 activation was completely blocked by the caspase-9 inhibitor LEHD-fmk (Fig. 2E) 
TUNEL staining for the transfected cells was conducted by following the protocol described by the manufacturer (Roche Applied Science, Indianapolis, IN). Immunostaining with the Myc tag antibody was performed as described. The images were analysed with Nikon inverted fluorescence microscopy (Model TE-2000U).
Data analysis
Results
Proteasome inhibition by MG-132 precedes mitochondria depolarization
Proteasomal inhibition leads to proteolytic activation of PKC␦
Recently, we demonstrated that PKC␦ is highly expressed in mouse nigral dopamine neurons [24] , and that kinase can be proteolytically activated by caspase-3 during oxidative stress-induced dopaminergic degeneration [16, 18, 21, 23, 26] (Fig. 3A and C) . The proteolytic cleavage was caspase-3-dependent, since it was diminished markedly by the caspase-3 inhibitor zDEVD-fmk (50 M), as well as by the pan-caspase inhibitor zVAD-fmk (100 M) (Fig. 3A) (Fig. 4C) . This finding suggests that the proapoptotic effect of PKC␦ proceeds through the mitochondria-mediated apoptosis pathway.
Mitochondrial translocation of active PKC␦ induces apoptosis
Next, we examined whether activated PKC␦ translocates to subcellular organelles to promote its proapoptotic function. As shown in Fig. 5A, MG-132 treatment resulted in substantial and timedependent accumulation of cleaved PKC␦ in the mitochondrial fraction, and only a slight elevation of full-length PKC␦ was observed. COX IV protein was used as marker of mitochondrial protein in the Western blot analysis (Fig. 5A). Together, these results indicate proteasomal inhibition proteolytically activates PKC␦ and causes translocation to mitochondria. To understand whether mitochondrial translocation of PKC␦-CF is functionally related to its proapoptotic effect, mitochondriatargeted expression of PKC␦-CF and PKC␦-RF was achieved performed with pCMV/myc/mito vector. Double immunostaining for myc tag (red) and active caspase-3 (green) revealed activation of caspase-3 in the PKC␦-CF transfected cells, but not in the PKC-RF or LacZ transfected cells (Fig. 5B). Also, cells transfected with PKC␦-CF, but not PKC␦-RF or LacZ, were TUNEL positive (Fig. 5C). Collectively, these results demonstrate that mitochondrial translocation of PKC␦-CF can amplify the apoptotic cascade during proteasomal dysfunction.
Suppression of PKC␦ proteolytic activation protects cells from mitochondria-mediated apoptosis following proteasome inhibitor exposure
To further substantiate that proteolytic activation is primarily responsible for the feedback amplification of mitochondria-mediated apoptotic signalling during dopaminergic apoptosis, a caspase-3 cleavage-resistant mutant of PKC␦ (PKC␦
D327A , PKC␦-CRM) was introduced into N27 cells using a lentivirus expression system and cells stably expressing PKC␦-CRM were generated. PKC␦-CRM expressing cells are more resistant to MG-132-induced PKC␦ proteolytic cleavage (Fig. 6A). Furthermore, the PKC␦-CRM cells were more resistant to MG-132-induced mitochondria-mediated apoptosis, as demonstrated by the significant reduction of caspase-9, caspase-3 activation, and DNA fragmentation compared to LacZ-transfected cells (Fig. 6B-D). Together, these results demonstrate proteolytic activation of PKC␦ promotes apoptotic cell death via a feedback amplification of the mitochondria-mediated caspase cascade.
Inhibition of mitochondria-mediated apoptosis by PKC␦ siRNA
To further confirm the critical role of PKC␦ in mitochondriamediated apoptosis during proteasome inhibition, we used a RNAi approach. siRNA duplex specifically targeting PKC␦ [16, 24] was introduced into N27 cells using electroporation transfection, and then caspase-9, caspase-3, and DNA fragmentation were assayed. The results revealed a remarkable inhibitory effect of siRNA-PKC␦ on the activation of caspase-9 (Fig. 7A) , caspase-3 (Fig. 7B ) and DNA fragmentation (Fig. 7C) . Nonspecific siRNA treatment did not alter these apoptotic markers. Again, a positive feedback loop would in part explain the observed inhibition of caspase-9 activation by PKC␦ siRNA (Fig. 7A) . [28, 29] . Mutations in genes of the ubiquitin ligase Parkin and the deubiquitin enzyme UchL-1 in familial PD have provided further evidence for the contributory roles of impaired UPS function in PD [2, 30, 31] . Notably, proteasome inhibitors have been shown to reproduce some key features of PD, including neuronal death [32] [33] [34] . However, underlying cell death mechanisms during UPS dysfunction remain to be determined. Recently, we and other have shown that dopaminergic neurons in mesencephalic culture are more susceptible to proteasomal inhibition than non-dopaminergic cells [15, 28, 32, 33, 35] . [15] . In the present study, we showed substantial reduction of proteasomal activity shortly after exposure to a low dose (5.0 M) of MG-132 (70%, Fig. 1A) , which was followed by progressive dissipation of mitochondrial membrane potential (Fig. 1B) . Mitochondrial depolarization has been extensively observed during apoptosis, concurrent with mitochondrial release of proapoptotic molecules in apoptosis models, including PD models [36] . Following MG-132 treatment, cytosolic cytochrome c and Smac levels progressively increased in N27 cells (Fig. 2A ) (Fig. 2B) . [38, 39] . It has also been shown that accumulation of ubiquitinated proteins can facilitate the formation of macroautophagy, a process in which impaired organelles including mitochondria, are targeted for degradation by lysosome [40] . Presently, it is unclear whether proteasome inhibition in neuronal cells can (Fig. 2C and D) . Unexpectedly, caspase-8 and -9 activities were slightly but significantly reduced at early stages (up to 60 min) of MG-132 treatment (Fig. 2C) , presumably due to compensatory action of anti-apoptotic proteins such as IAPs or Mcl-1 upon proteasome inhibition [41, 42] [45] . Previously, we showed that proteolytically activated PKC␦ plays a key role in mediating oxidative stress-induced apoptosis in dopaminergic neuronal cells [16, 18, 21, 46] (Fig. 3A-C) . The direct proapoptotic effect of PKC␦-CF is manifested by the elevation of caspase-3 activity in PKC␦-CF transfected cells (Fig. 4B) , consistent with apoptotic function of PKC␦ proteolytic activation. In addition, PKC␦ likely enhances activation of caspase-9, which further activates the downstream effector caspase-3, since the PKC␦-specific inhibitor rottlerin attenuates activation of caspase-3 and upstream initiator caspase-9, at least in our study (Fig. 4C and D) . Emerging evidence has indicated that rottlerin, a previously wellaccepted specific inhibitor for PKC␦, actually possesses some biological function other than PKC␦ inhibition, such as uncoupling mitochondria [48] . Rottlerin [53] , MG-132, lactacystin [54] , and PS-341 [55] in several non-neuronal cell lines. Oxidative stress has been demonstrated to activate caspase-3 and PKC␦ in N27 cells [18, 23] . In an attempt to determine whether dopaminergic apoptosis following MG-132 exposure involves oxidative stress, ROS generation was measured; no significant increase in ROS generation was noted (Fig. 1C and D) . Additionally, the antioxidant MnTBAP, which has been previously shown to effectively inhibit caspase-3 activation during oxidative stress in N27 cells [18] , failed to attenuate caspase-3 activation induced by (Fig. 4E) [56] . PKC␦ has been shown to accumulate in nuclei [57] , golgi [58] and endoplasmic reticulum [59] in various cell types. In an attempt to determine whether mitochondrial translocation of proteolytically activated PKC␦ underlies its proapoptotic effect, marked activation of caspase-3 was noted in the N27 cells expressing mitochondria targeted PKC␦-CF (Fig. 5B) (Fig. 6A) , significantly attenuated the activation of mitochondria-mediated apoptosis triggered by (Fig. 6B-D [60] and pyruvate dehydrogenase kinase [61] . Likely, elevated levels of BAD, due to its incomplete degradation by the proteasome, also participates in the mitochondria-dependent proapoptotic effect of PKC␦ in dopaminergic cells, given the previous finding that PKC␦ mitochondrial translocation is accompanied by an increase in the level of BAD following cardiac ischaemia [62] . We also recently reported that systemic administration of PKC␦ inhibitor alleviates the nigrostriatal dopaminergic degeneration in an MPTP-induced animal model of PD; PKC␦ inhibitor has been previously shown to supress dopaminergic apoptosis involving proteolytic activation of PKC␦ in the N27 cells [18, 24] . Therefore 
Collectively, these results clearly confirm that PKC␦ regulates the mitochondria-mediated apoptotic cascade following proteasomal dysfunction in dopaminergic neuronal cells. © 2008 The Authors Journal compilation © 2008 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Discussion
The present study reveals an important regulatory role of PKC␦ in mitochondria-mediated apoptosis in mesencephalic dopaminergic neuronal cells following proteasome inhibition. We demonstrated activation of the mitochondria-mediated apoptosis cascade and proteolytic activation of PKC␦ during proteasome inhibition. Importantly, we found that proteolytic activation and mitochondrial translocation of PKC␦ underlie its positive feedback amplification of mitochondriamediated apoptosis during proteasome dysfunction in mesencephalic dopaminergic neuronal cells. This mitochondria-dependent proapoptotic capacity of PKC␦ sheds light on degenerative processes of dopaminergic neurons mediated by UPS dysfunction in PD.
In addition to mitochondria dysfunction and oxidative stress, UPS dysfunction has recently been recognized as a key pathophysiological process of PD. Previous studies have revealed that the substantia nigra particularly suffers from UPS dysfunction in the brains of patients with sporadic PD
Additionally, we have shown dopaminergic neurons in nigral regions are more sensitive than non-dopaminergic cells following intra-nigral injection of MG-132
. It appears that mitochondrial release of cytochrome c occurred as a consequence of proteasome inhibition by MG-132, but not due to a direct stimulatory effect of MG-132 on mitochondria, because incubation of isolated mitochondria with MG-132 failed to trigger mitochondrial release of cytochrome c
Several proteins important for regulation of mitochondria-depend-
